Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE₂/EP4 Signaling Pathway

References

• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019. doi:10.1038/nrdp.2015.19
   PubMed Web of Science ®Google Scholar
• Zhou P, Xie W, He S, et al. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells. 2019;8(3):204. doi:10.3390/cells8030204
   PubMed Web of Science ®Google Scholar
• Flamment M, Hajduch E, Ferré P, Foufelle F. New insights into ER stress-induced insulin resistance. Trends Endocrinol Metab. 2012;23(8):381–390. doi:10.1016/j.tem.2012.06.003
   PubMed Web of Science ®Google Scholar
• Titchenell PM, Lazar MA, Birnbaum MJ. Unraveling the Regulation of Hepatic Metabolism by Insulin. Trends Endocrinol Metab. 2017;28(7):497–505. doi:10.1016/j.tem.2017.03.003
   PubMed Web of Science ®Google Scholar
• Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4(1):177–197. doi:10.1002/cphy.c130024
   PubMed Web of Science ®Google Scholar
• Liu TY, Shi CX, Gao R, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Clin Sci (Lond). 2015;129(10):839–850. doi:10.1042/cs20150009
   PubMed Web of Science ®Google Scholar
• Wang W, Liang M, Wang L, et al. Role of prostaglandin E2 in macrophage polarization: insights into atherosclerosis. Biochem Pharmacol. 2023;207:115357. doi:10.1016/j.bcp.2022.115357
   PubMed Web of Science ®Google Scholar
• Wang W, Zhong X, Guo J. Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review). Int J Mol Med. 2021;47(6):114. doi:10.3892/ijmm.2021.4947
   PubMed Web of Science ®Google Scholar
• Okumura T, Kanemaki T, Kitade H. Stimulation of glucose incorporation into glycogen by E-series prostaglandins in cultured rat hepatocytes. Biochim Biophys Acta. 1993;1176(1–2):137–142. doi:10.1016/0167-4889(93)90188-u
   PubMedGoogle Scholar
• Henkel J, Coleman CD, Schraplau A, et al. Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model. Sci Rep. 2018;8(1):16127. doi:10.1038/s41598-018-34633-y
   PubMed Web of Science ®Google Scholar
• Henkel J, Frede K, Schanze N, et al. Stimulation of fat accumulation in hepatocytes by PGE2-dependent repression of hepatic lipolysis, β-oxidation and VLDL-synthesis. Lab Invest. 2012;92(11):1597–1606. doi:10.1038/labinvest.2012.128
   PubMed Web of Science ®Google Scholar
• Zhang Y, Desai A, Yang SY, et al. TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science. 2015;348(6240):aaa2340. doi:10.1126/science.aaa2340
   PubMed Web of Science ®Google Scholar
• Yao L, Chen W, Song K, et al. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury. PLoS One. 2017;12(4):e0176106. doi:10.1371/journal.pone.0176106
   PubMed Web of Science ®Google Scholar
• Liang M, Wang L, Wang W. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE2–EP4 receptor–AKT signaling in a type 2 diabetes mellitus mouse model. Cell Signal. 2023;108:110707. doi:10.1016/j.cellsig.2023.110707
   PubMed Web of Science ®Google Scholar
• Mohanan P, Subramaniyam S, Mathiyalagan R, Yang DC. Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J Ginseng Res. 2018;42(2):123–132. doi:10.1016/j.jgr.2017.01.008
   PubMed Web of Science ®Google Scholar
• Ratan ZA, Haidere MF, Hong YH, et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res. 2021;45(2):199–210. doi:10.1016/j.jgr.2020.02.004
   PubMed Web of Science ®Google Scholar
• Wu Y, Yu Y, Szabo A, Han M, Huang XF. Central inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat diet. PLoS One. 2014;9(3):e92618. doi:10.1371/journal.pone.0092618
   PubMed Web of Science ®Google Scholar
• Yu X, Ye L, Zhang H, et al. Ginsenoside Rb1 ameliorates liver fat accumulation by upregulating perilipin expression in adipose tissue of db/db obese mice. J Ginseng Res. 2015;39(3):199–205. doi:10.1016/j.jgr.2014.11.004
   PubMed Web of Science ®Google Scholar
• Wang W, Zhan W, Liang M, et al. Ginsenoside Rb1 ameliorates the abnormal hepatic glucose metabolism by activating STAT3 in T2DM mice. J Funct Foods. 2023;104:105534. doi:10.1016/j.jff.2023.105534
   Web of Science ®Google Scholar
• Dai S, Liu S, Li C, Zhou Z, Wu Z. Site-selective modification of exendin 4 with variable molecular weight dextrans by oxime-ligation chemistry for improving type 2 diabetic treatment. Carbohydr Polym. 2020;249:116864. doi:10.1016/j.carbpol.2020.116864
   PubMed Web of Science ®Google Scholar
• Parilla JH, Willard JR, Barrow BM, Zraika S. A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes. J Diabetes Res. 2018;2018:6106051. doi:10.1155/2018/6106051
   PubMed Web of Science ®Google Scholar
• Dong JY, Xia KJ, Liang W, et al. Ginsenoside Rb1 alleviates colitis in mice via activation of endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 signaling pathway. Acta Pharmacol Sin. 2021;42(9):1461–1471. doi:10.1038/s41401-020-00561-9
   PubMed Web of Science ®Google Scholar
• Lou MD, Li J, Cheng Y, et al. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1. Br J Pharmacol. 2019;176(16):2962–2976. doi:10.1111/bph.14758
   PubMed Web of Science ®Google Scholar
• Zhang C, Han M, Zhang X, Tong H, Sun X, Sun G. Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway. J Inflamm Res. 2022;15:71–83. doi:10.2147/jir.S348866
   PubMed Web of Science ®Google Scholar
• Terasaki M, Hiromura M, Mori Y, et al. Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice. PLoS One. 2015;10(11):e0143396. doi:10.1371/journal.pone.0143396
   PubMed Web of Science ®Google Scholar
• Wang X, Chen S, Lu R, et al. Adipose-derived stem cell-secreted exosomes enhance angiogenesis by promoting macrophage M2 polarization in type 2 diabetic mice with limb ischemia via the JAK/STAT6 pathway. Heliyon. 2022;8(11):e11495. doi:10.1016/j.heliyon.2022.e11495
   PubMed Web of Science ®Google Scholar
• Biggs EK, Liang L, Naylor J, et al. Development and characterisation of a novel glucagon like peptide-1 receptor antibody. Diabetologia. 2018;61(3):711–721. doi:10.1007/s00125-017-4491-0
   PubMed Web of Science ®Google Scholar
• Li L, Xue J, Wan J, et al. LRP6 Knockdown Ameliorates Insulin Resistance via Modulation of Autophagy by Regulating GSK3β Signaling in Human LO2 Hepatocytes. Front Endocrinol (Lausanne). 2019;10:73. doi:10.3389/fendo.2019.00073
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang S, Zhu Z, et al. Upregulation of adiponectin by Ginsenoside Rb1 contributes to amelioration of hepatic steatosis induced by high fat diet. J Ginseng Res. 2022;46(4):561–571. doi:10.1016/j.jgr.2021.10.005
   PubMed Web of Science ®Google Scholar
• Gursan A, Prompers JJ. Magnetic Resonance Imaging and Spectroscopy Methods to Study Hepatic Glucose Metabolism and Their Applications in the Healthy and Diabetic Liver. Metabolites. 2022;12(12):1223. doi:10.3390/metabo12121223
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Nakamura Y, Umeno J. Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action. Pharmacol Ther. 2021;223:107803. doi:10.1016/j.pharmthera.2021.107803
   PubMed Web of Science ®Google Scholar
• Yasui M, Tamura Y, Minami M, et al. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity. PLoS One. 2015;10(8):e0136304. doi:10.1371/journal.pone.0136304
   PubMed Web of Science ®Google Scholar
• Yasui-Kato M, Patlada S, Yokode M, Kamei K, Minami M. EP4 signalling is essential for controlling islet inflammation by causing a shift in macrophage polarization in obesity/type 2 diabetes. Diab Vasc Dis Res. 2020;17(4):1479164120945675. doi:10.1177/1479164120945675
   Web of Science ®Google Scholar
• Gourdy P, Darmon P, Dievart F, Halimi JM, Guerci B. Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM). Cardiovasc Diabetol. 2023;22(1):79. doi:10.1186/s12933-023-01798-4
   PubMed Web of Science ®Google Scholar
• Ishii H, Hayashino Y, Akai Y, Yabuta M, Tsujii S. Dipeptidyl peptidase-4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: results from a multicenter, 12-week, open label, randomized controlled study in Japan (PREFERENCE 4 study). J Diabetes Investig. 2018;9(1):137–145. doi:10.1111/jdi.12659
   PubMed Web of Science ®Google Scholar
• Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 2017;13(10):572–587. doi:10.1038/nrendo.2017.80
   PubMed Web of Science ®Google Scholar
• Ren T, Ma A, Zhuo R, et al. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model. J Pharmacol Exp Ther. 2020;373(1):81–91. doi:10.1124/jpet.119.262675
   PubMed Web of Science ®Google Scholar
• Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol. 2007;47(1):142–156. doi:10.1016/j.jhep.2007.04.002
   PubMed Web of Science ®Google Scholar
• Shen L, Haas M, Wang DQ, et al. Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats. Physiol Rep. 2015;3(9):e12543. doi:10.14814/phy2.12543
   PubMedGoogle Scholar
• Palla AR, Ravichandran M, Wang YX, et al. Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science. 2021;371(6528):eabc8059. doi:10.1126/science.abc8059
   PubMed Web of Science ®Google Scholar
• Sun CC, Zhou ZQ, Yang D, et al. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. Int Immunopharmacol. 2021;101(Pt B):108176. doi:10.1016/j.intimp.2021.108176
   PubMed Web of Science ®Google Scholar
• Miao S, Lv C, Liu Y, et al. Pharmacologic Blockade of 15-PGDH Protects Against Acute Renal Injury Induced by LPS in Mice. Front Physiol. 2020;11:138. doi:10.3389/fphys.2020.00138
   PubMed Web of Science ®Google Scholar
• Bärnthaler T, Theiler A, Zabini D, et al. Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue. J Allergy Clin Immunol. 2020;145(3):818–833. doi:10.1016/j.jaci.2019.11.032
   PubMed Web of Science ®Google Scholar
• Myung SJ, Rerko RM, Yan M, et al. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci U S A. 2006;103(32):12098–12102. doi:10.1073/pnas.0603235103
   PubMed Web of Science ®Google Scholar
• Tai HH, Cho H, Tong M, Ding Y. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des. 2006;12(8):955–962. doi:10.2174/138161206776055958
   PubMed Web of Science ®Google Scholar
• Zhou H, Yan F, Tai HH. C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates. Eur J Biochem. 2001;268(12):3368–3374. doi:10.1046/j.1432-1327.2001.02218.x
   PubMedGoogle Scholar
• Wang W, Hu Y, Wang X, Wang Q, Deng H. ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD(+)-Mediated Epithelial-Mesenchymal Transition. Cell Chem Biol. 2018;25(3):255–261. doi:10.1016/j.chembiol.2017.12.008
   PubMed Web of Science ®Google Scholar
• Cheng H, Huang H, Guo Z, Chang Y, Li Z. Role of prostaglandin E2 in tissue repair and regeneration. Theranostics. 2021;11(18):8836–8854. doi:10.7150/thno.63396
   PubMed Web of Science ®Google Scholar